National Pension Service Makes New $699,000 Investment in Revvity Inc. $RVTY

National Pension Service acquired a new stake in Revvity Inc. (NYSE:RVTY) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 7,979 shares of the company’s stock, valued at approximately $699,000.

A number of other hedge funds and other institutional investors have also modified their holdings of RVTY. EdgePoint Investment Group Inc. lifted its stake in shares of Revvity by 26.7% in the second quarter. EdgePoint Investment Group Inc. now owns 6,789,660 shares of the company’s stock worth $656,696,000 after acquiring an additional 1,428,813 shares in the last quarter. Norges Bank purchased a new stake in Revvity during the 2nd quarter worth approximately $124,574,000. Allspring Global Investments Holdings LLC raised its position in shares of Revvity by 14,741.7% in the 3rd quarter. Allspring Global Investments Holdings LLC now owns 771,470 shares of the company’s stock valued at $70,790,000 after purchasing an additional 766,272 shares in the last quarter. Invesco Ltd. boosted its stake in shares of Revvity by 25.8% during the 2nd quarter. Invesco Ltd. now owns 2,207,202 shares of the company’s stock valued at $213,481,000 after buying an additional 452,343 shares during the last quarter. Finally, Amundi boosted its stake in shares of Revvity by 157.0% during the 2nd quarter. Amundi now owns 519,987 shares of the company’s stock valued at $52,467,000 after buying an additional 317,643 shares during the last quarter. 86.65% of the stock is owned by hedge funds and other institutional investors.

Revvity Stock Down 5.8%

NYSE:RVTY opened at $100.85 on Wednesday. The company has a current ratio of 1.68, a quick ratio of 1.44 and a debt-to-equity ratio of 0.36. The stock has a 50 day moving average of $103.99 and a 200-day moving average of $95.57. The firm has a market capitalization of $11.43 billion, a PE ratio of 48.49, a price-to-earnings-growth ratio of 3.22 and a beta of 1.07. Revvity Inc. has a 52 week low of $81.36 and a 52 week high of $124.82.

Revvity (NYSE:RVTY) last released its quarterly earnings data on Monday, February 2nd. The company reported $1.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.15. The business had revenue of $772.06 million during the quarter, compared to analyst estimates of $759.81 million. Revvity had a return on equity of 7.92% and a net margin of 8.45%.The business’s revenue for the quarter was up 5.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.42 EPS. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. Analysts predict that Revvity Inc. will post 4.94 EPS for the current year.

Revvity Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, May 8th. Stockholders of record on Friday, April 17th will be issued a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, April 17th. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. Revvity’s payout ratio is 14.07%.

Revvity declared that its board has initiated a share repurchase plan on Monday, October 27th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the company to purchase up to 8.7% of its shares through open market purchases. Shares buyback plans are generally a sign that the company’s leadership believes its stock is undervalued.

Revvity News Summary

Here are the key news stories impacting Revvity this week:

• Positive Sentiment: Q4 beats and raised guidance — Revvity reported Q4 adjusted EPS of $1.70 (ahead of estimates) and revenue of $772.06M, and gave FY2026 EPS guidance of $5.35–$5.45 and revenue guidance near $3.0B. These results and guidance are the primary catalyst lifting the stock. Press Release / Slide Deck
• Positive Sentiment: TD Cowen raised its price target to $124 and maintained a Buy — a sizable upside projection (~23% from current levels) that likely supports buying interest. TD Cowen PT Raise
• Positive Sentiment: Wells Fargo lifted its target to $110 with an Equal Weight rating — another upward revision reinforcing the post-earnings re-rating. Wells Fargo Note
• Neutral Sentiment: JPMorgan raised its target modestly to $105 but kept a Neutral rating — a smaller upgrade that tempers some upside expectations. JPMorgan Note
• Positive Sentiment: Analyst write-ups and momentum screens (Zacks, Benzinga) are flagging Revvity as a momentum/upgrade name after the print, which can attract short-term flows and momentum traders. Zacks Momentum Piece
• Neutral Sentiment: Analyst commentary is mixed on valuation — Seeking Alpha and DCF-focused pieces note the stock is “close to a buy” but point to valuation/DCF gaps, suggesting upside may be contingent on sustained execution. Seeking Alpha Analysis
• Neutral Sentiment: Earnings transcripts and call highlights are available for deeper diligence — read the company’s prepared remarks and slides for segment-level drivers and margin outlook. Earnings Call Transcript

Analyst Upgrades and Downgrades

RVTY has been the subject of a number of research analyst reports. Weiss Ratings restated a “sell (d)” rating on shares of Revvity in a research note on Monday, December 29th. Barclays boosted their price objective on Revvity from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Tuesday. Wells Fargo & Company increased their target price on Revvity from $107.00 to $110.00 and gave the stock an “equal weight” rating in a report on Tuesday. JPMorgan Chase & Co. lifted their target price on Revvity from $100.00 to $105.00 and gave the stock a “neutral” rating in a research report on Tuesday. Finally, Robert W. Baird set a $129.00 price objective on Revvity in a research note on Tuesday. Five equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $113.67.

Revvity Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.